Omicron BA.2.75 subvariant of SARS-CoV-2 is expected to have the greatest infectivity compared with the competing BA.2 and BA.5, due to most negative Gibbs energy of binding.
Чланак у часопису (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Omicron BA.2.75 may become the next globally dominant strain of COVID-19 in 2022. The BA.2.75 sub-variant has acquired more mutations (9) in spike protein and other genes of SARS-CoV-2 than any other variant. Thus, its chemical composition and thermodynamic properties have changed compared with earlier variants. In this paper, the Gibbs energy of the binding and antigen-receptor binding rate was reported for the BA.2.75 variant. Gibbs energy of the binding of the Omicron BA.2.75 variant is more negative than that of the competing variants BA.2 and BA.5.
Кључне речи:
BA.2.75 variant / Gibbs energy of binding / binding rate / infectivity / SARS-CoV-2 / phenomenological equation / nonequilibrium thermodynamics / chemical kinetics / OmicronИзвор:
BioTech, 2022, 11, 4, 45-Издавач:
- MDPI
DOI: 10.3390/biotech11040045
ISSN: 2673-6284
PubMed: 36278557
Scopus: 2-s2.0-85140880095
Институција/група
IHTMTY - JOUR AU - Popović, Marko PY - 2022 UR - https://cer.ihtm.bg.ac.rs/handle/123456789/6111 AB - Omicron BA.2.75 may become the next globally dominant strain of COVID-19 in 2022. The BA.2.75 sub-variant has acquired more mutations (9) in spike protein and other genes of SARS-CoV-2 than any other variant. Thus, its chemical composition and thermodynamic properties have changed compared with earlier variants. In this paper, the Gibbs energy of the binding and antigen-receptor binding rate was reported for the BA.2.75 variant. Gibbs energy of the binding of the Omicron BA.2.75 variant is more negative than that of the competing variants BA.2 and BA.5. PB - MDPI T2 - BioTech T1 - Omicron BA.2.75 subvariant of SARS-CoV-2 is expected to have the greatest infectivity compared with the competing BA.2 and BA.5, due to most negative Gibbs energy of binding. VL - 11 IS - 4 SP - 45 DO - 10.3390/biotech11040045 ER -
@article{ author = "Popović, Marko", year = "2022", abstract = "Omicron BA.2.75 may become the next globally dominant strain of COVID-19 in 2022. The BA.2.75 sub-variant has acquired more mutations (9) in spike protein and other genes of SARS-CoV-2 than any other variant. Thus, its chemical composition and thermodynamic properties have changed compared with earlier variants. In this paper, the Gibbs energy of the binding and antigen-receptor binding rate was reported for the BA.2.75 variant. Gibbs energy of the binding of the Omicron BA.2.75 variant is more negative than that of the competing variants BA.2 and BA.5.", publisher = "MDPI", journal = "BioTech", title = "Omicron BA.2.75 subvariant of SARS-CoV-2 is expected to have the greatest infectivity compared with the competing BA.2 and BA.5, due to most negative Gibbs energy of binding.", volume = "11", number = "4", pages = "45", doi = "10.3390/biotech11040045" }
Popović, M.. (2022). Omicron BA.2.75 subvariant of SARS-CoV-2 is expected to have the greatest infectivity compared with the competing BA.2 and BA.5, due to most negative Gibbs energy of binding.. in BioTech MDPI., 11(4), 45. https://doi.org/10.3390/biotech11040045
Popović M. Omicron BA.2.75 subvariant of SARS-CoV-2 is expected to have the greatest infectivity compared with the competing BA.2 and BA.5, due to most negative Gibbs energy of binding.. in BioTech. 2022;11(4):45. doi:10.3390/biotech11040045 .
Popović, Marko, "Omicron BA.2.75 subvariant of SARS-CoV-2 is expected to have the greatest infectivity compared with the competing BA.2 and BA.5, due to most negative Gibbs energy of binding." in BioTech, 11, no. 4 (2022):45, https://doi.org/10.3390/biotech11040045 . .